Science Explorer Back to mapMap
Discussion
Researcher · University College London · United Kingdom

M Kivimaki

M Kivimaki publishes mostly in Biological Psychiatry, Neurology and Cellular and Molecular Neuroscience, on topics such as Tryptophan and brain disorders, Amyotrophic Lateral Sclerosis Research and Genetic Neurodegenerative Diseases.

ORCID 0000-0002-4699-5627 OpenAlex
World rank
#7,330,558
of 7,710,434 ranked researchers
Rank in United Kingdom
#362,454
of 367,258
Works
33
Citations
0
h-index
0
i10-index 0Top 100% in Biological Psychiatry
M Kivimaki

What does M Kivimaki research?

M Kivimaki's work is mostly in Neuroscience (50%), Medicine (32%), Environmental Science (3%).

Life Sciences: 16 works · 50.0% of their workNeuroscience: 16 works · 50.0% of their workBiological Psychiatry: 9 works · 26.1% of their workCellular and Molecular Neuroscience: 8 works · 23.9% of their workHealth Sciences: 10 works · 31.5% of their workMedicine: 10 works · 31.5% of their workNeurology: 9 works · 26.1% of their workPsychiatry and Mental health: 2 works · 5.4% of their workEverything else: 4 works · 11.9% of their workPhysical Sciences: 1 works · 3.3% of their workEnvironmental Science: 1 works · 3.3% of their workHealth, Toxicology and Mutagenesis: 1 works · 3.3% of their workSocial Sciences: 1 works · 3.3% of their workSocial Sciences: 1 works · 3.3% of their workHealth: 1 works · 3.3% of their workTHEIR WORKM Kivimaki33works
Life Sciences50%Physical Sciences3%Health Sciences32%Social Sciences3%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Neuroscience1650.0%
    1. Medicine1031.5%
  3. Everything else411.9%
    1. Environmental Science13.3%
    1. Social Sciences13.3%
  1. 1Biological Psychiatry26% of their works
  2. 2Neurology26% of their works
  3. 3Cellular and Molecular Neuroscience24% of their works
  4. 4Psychiatry and Mental health5% of their works
  5. 5Health, Toxicology and Mutagenesis3% of their works
  6. 6Health3% of their works

Research topics

Which keywords describe M Kivimaki's research?

The keywords of their largest research topics: Neurodegeneration, Neuroinflammation, Oxidative Stress, Cytokines, Genetics, Microglia, Depression and FUS/TLS.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Neurodegeneration293 topics
  2. Neuroinflammation293 topics
  3. Oxidative Stress272 topics
  4. Cytokines262 topics
  5. Genetics262 topics
  6. Microglia262 topics
  7. Depression241 topic
  8. FUS/TLS241 topic
  9. TDP-43241 topic
  10. Tryptophan Metabolism241 topic
  11. Huntington's Disease221 topic
  12. Protein Aggregation221 topic
  13. Public Health52 topics
  14. Amyloid Hypothesis31 topic
  15. Antipsychotic Drugs31 topic
  16. Neurocognitive Deficits31 topic
  17. Social Relationships31 topic
  18. Socioeconomic Inequalities31 topic
  19. Tau Pathology31 topic
  20. Astrocytes21 topic
  21. Environmental Exposure21 topic
  22. Exposome21 topic
  23. Synaptic Pruning21 topic

Where does M Kivimaki work?

M Kivimaki's main affiliation in the publication record is University College London, United Kingdom.

How many publications and citations does M Kivimaki have?

OpenAlex counts 33 works and 0 citations for M Kivimaki, an h-index of 0, ranking #7,330,558 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about M Kivimaki. Posts are plain text and can be reported.